About
Antibody Therapeutics
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
81
By Phase
PHASE2: 1PHASE1: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07213583Lead Sponsor
Study of Re-Treatment With ALXN2220 in Patients With ATTR-CM
PHASE2Recruiting
35 participants
Started: Aug 28, 2025 · Completed: Oct 31, 2026
NCT04360434Lead Sponsor
First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy
PHASE1Completed
46 participants
Started: Feb 10, 2020 · Completed: Jul 26, 2023
Locations (1)
Headquarters
Schlieren, Switzerland
Map
Loading map...